agilon health layoffs, on the record
Every job cut, severance charge and restructuring agilon health reported in its annual reports, 2023 to 2025, quoted from the filings. Headcount went from 1,117 to 1,076.
Headcount, as reported
| Annual report | Employees | As of |
|---|---|---|
| 10-K for 2023 | 1,117 | December 31, 2023 |
| 10-K for 2024 | 1,076 | December 31, 2024 |
Job cuts, severance and restructuring
Our summaryThe company reported severance and related costs in its Adjusted EBITDA reconciliation for 2023, which were small compared with prior years.
Word for word“Severance and related costs (1) 188 2,470 12,360 Stock-based compensation expense 69,326 28,069 291,672 EBITDA adjustments related to equity method investments (2) 22,694 3,737 1,736 Other (3) (15,448) (7,967) 5,836 Adjusted EBITDA (4) $ (95,001) $ (45,470) $ (54,742)” 10-K for 2023
Our summaryThe company paid a severance payment of $3.7 million to its former chief executive officer, contingent on completing the IPO.
Word for word“The Company also recognized $ 2.6 million of expense related to stock options that vested upon the completion of the IPO in 2021 and $ 3.7 million of expense related to a severance payment to its former chief executive officer contingent upon the completion of the IPO.” 10-K for 2023
Our summaryThe filing reports severance and related costs recorded in the reconciliation of net income to Adjusted EBITDA for the year ended December 31, 2024.
Word for word“Severance and related costs 4,577 188 2,470 Stock-based compensation expense 50,657 69,326 28,069 EBITDA adjustments related to equity method investments (1) 17,582 22,694 3,737 Other (2) (12,441) (15,448) (7,967) Adjusted EBITDA $ (154,215) $ (95,001) $ (45,470) _____________________________________________________________________ (1) Includes elimination of certain administrative services provided by us to our equity method investments.” 10-K for 2024
Our summaryThe company reported lower severance and transaction-related costs in 2025, driven by 2024 partnership exits, partly offset by costs from the former CEO's departure and strategic workforce changes.
Word for word“Costs incurred for severance and transaction-related costs decreased by $13.0 million to $7.3 million in 2025 compared to $20.3 million in 2024 primarily due to partnership exits during 2024, partially offset by the costs associated with the departure of our former Chief Executive Officer in 2025, as well as costs related to strategic changes in our workforce.” 10-K for 2025
Our summaryThe Chief Executive Officer resigned and was given a severance package.
Word for word“On July 29, 2025, Steven Sell resigned as our Chief Executive Officer, President, and board member and was given a severance package.” 10-K for 2025
agilon health has filed no restructuring notice (Form 8-K, Item 2.05) since 2016. Companies file one only for a cut they judge material, so many announced layoffs never appear as one. This page shows what the company reported to the SEC, not news reports or state layoff notices.
Read from agilon health’s annual reports (10-K for 2025, 10-K for 2024, 10-K for 2023) and the financial data it files with the SEC, as of 2026-02-25. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.